Stern Benjamin, Gatinel Damien
Anterior Segment and Refractive Surgery Department, Rothschild Foundation Hospital, Paris, France.
Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Clin Exp Ophthalmol. 2025 Aug;53(6):668-681. doi: 10.1111/ceo.14535. Epub 2025 Apr 28.
Presbyopia affects approximately 1.8 billion individuals globally, posing significant challenges as life expectancy and near-vision demands, particularly with mobile phone use, grow. Addressing presbyopia during lens replacement surgery has become a key focus for cataract surgeons, aiming to reduce dependence on corrective eyewear. This review provides an overview of current intraocular lens (IOL) technologies and surgical strategies for presbyopia correction. Personalised decision-making is essential, considering each patient's visual needs, expectations, and ocular anatomy. Partial correction approaches, such as monovision and extended depth-of-focus IOLs, can improve intermediate vision but involve specific trade-offs compared to monofocal lenses, depending on the technology utilised. For complete presbyopia correction, multifocal IOLs remain the most effective option. A mix-and-match strategy involving unilateral multifocal implantation shows promise, while sulcus-fixated supplementary IOLs offer the advantage of easier reversibility. Careful IOL selection is particularly important for patients with atypical ocular anatomy or coexisting conditions, which may be progressive.
老花眼在全球约影响18亿人,随着预期寿命和近视力需求的增长,尤其是随着手机使用的增加,这带来了重大挑战。在晶状体置换手术中解决老花眼问题已成为白内障外科医生的关键关注点,旨在减少对矫正眼镜的依赖。本综述概述了当前用于矫正老花眼的人工晶状体(IOL)技术和手术策略。考虑到每个患者的视觉需求、期望和眼部解剖结构,个性化决策至关重要。部分矫正方法,如单眼视和扩展焦深人工晶状体,可以改善中间视力,但与单焦点晶状体相比,根据所采用的技术会涉及特定的权衡。对于完全矫正老花眼,多焦点人工晶状体仍然是最有效的选择。涉及单侧多焦点植入的混合搭配策略显示出前景,而沟内固定辅助人工晶状体具有更容易可逆的优势。对于具有非典型眼部解剖结构或共存疾病(可能是进行性的)的患者,仔细选择人工晶状体尤为重要。